摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,2-dimethylpentanamide

中文名称
——
中文别名
——
英文名称
N,2-dimethylpentanamide
英文别名
——
N,2-dimethylpentanamide化学式
CAS
——
化学式
C7H15NO
mdl
——
分子量
129.2
InChiKey
SFQLCGIXNRQKSW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    9
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

文献信息

  • TOLL LIKE RECEPTOR MODULATOR COMPOUNDS
    申请人:Gilead Sciences, Inc.
    公开号:US20160289229A1
    公开(公告)日:2016-10-06
    The present disclosure relates generally to toll like receptor modulator compounds, such as diamino pyrido[3,2 D]pyrimidine compounds and pharmaceutical compositions which, among other things, modulate toll-like receptors (e.g. TLR-8), and methods of making and using them.
    本公开涉及调节类似受体调节剂化合物,例如二氨基吡啶并[3,2 D]嘧啶化合物和药物组合物,其中调节类似受体(例如TLR-8),以及制备和使用它们的方法。
  • PROCESS FOR ALKENYLATING CARBOXAMIDES
    申请人:Staffel Wolfgang
    公开号:US20090131657A1
    公开(公告)日:2009-05-21
    The present invention relates to a process for preparing N-(1-alkenyl)carboxamides of the formula I, which comprises reacting a carboxamide of the formula II with an alkyne of the formula III in the presence of a catalyst selected from among carbonyl complexes, halides and oxides of rhenium, manganese, tungsten, molybdenum, chromium and iron.
    本发明涉及一种制备式I的N-(1-烯基)羧酰胺的方法,包括在选择自的羰基配合物、卤化物和氧化物之一作为催化剂的情况下,将式II的羧酰胺与式III的炔烃反应。
  • METHOD FOR PRODUCING BETA -ALKOXYPROPIONAMIDE
    申请人:Idemitsu Kosan Co., Ltd
    公开号:EP2837619A1
    公开(公告)日:2015-02-18
    A method for producing a β-alkoxypropionamide including reacting a β-alkoxypropionic acid ester represented by the following formula (1) and an amine represented by the following formula (2) in the presence of a polyol and a basic catalyst, thereby to produce a β-alkoxypropionamide represented by the following formula (3), wherein, as the polyol, a reaction residue that is generated by the reaction and contains a used polyol is used: (wherein in the formulas, R and R' are independently a C1 to C6 linear, branched or cyclic, saturated hydrocarbon group; R1 and R2 are independently a C1 to C6 linear, branched or cyclic, saturated hydrocarbon group; and R3 is H or CH3).
    生产β-烷氧基丙酰胺的方法包括在多元醇和碱性催化剂存在下,使以下式(1)所代表的β-烷氧基丙酸酯与以下式(2)所代表的胺发生反应,从而生成以下式(3)所代表的β-烷氧基丙酰胺, 其中作为多元醇,使用由反应生成并含有已使用的多元醇的反应残留物:(在公式中,R和R'分别是C1到C6的直链、支链或环状饱和碳氢基团;R1和R2分别是C1到C6的直链、支链或环状饱和碳氢基团;R3是H或CH3)。
  • Ionic Liquids for Separation of Olefin-Paraffin Mixtures
    申请人:Dai Sheng
    公开号:US20110015461A1
    公开(公告)日:2011-01-20
    The invention is directed to an ionic liquid comprising (i) a cationic portion containing a complex of a silver (I) ion and one or more neutral ligands selected from organoamides, organoamines, olefins, and organonitriles, and (ii) an anionic portion having the chemical formula wherein m and n are independently 0 or an integer of 1 or above, and p is 0 or 1, provided that when p is 0, the group —N—SO 2 —(CF 2 ) n CF 3 subtended by p is replaced with an oxide atom connected to the shown sulfur atom. The invention is also directed to a method for separating an olefin from an olefin-paraffin mixture by passing the mixture through a layer of the ionic liquid described above.
    该发明涉及一种离子液体,包括(i)含有(I)离子的阳离子部分,该离子与来自有机酰胺、有机胺、烯烃和有机腈中选择的一个或多个中性配体形成的络合物,以及(ii)具有化学式的阴离子部分,其中m和n独立地为0或大于1的整数,p为0或1,但当p为0时,由p支撑的基团—N—SO2—(CF2)nCF3将被连接到所示原子的氧原子替代。该发明还涉及一种从烯烃烷烃混合物中分离烯烃的方法,通过将混合物经过上述离子液体的一层来实现。
  • LONG HALF-LIFE RECOMBINANT BUTYRYLCHOLINESTERASE
    申请人:Huang Yue
    公开号:US20090208480A1
    公开(公告)日:2009-08-20
    The present invention provides for butyrylcholinesterase (BChE) attached to polyethylene glycol (PEG) to form a complex having greatly increased mean residence time (MRT) in the system of an animal following injection thereinto. Also disclosed are compositions of such complexes, methods of preparing these complexes and method for using these complexes and compositions in the treatment and/or prevention of toxic effects of poisons, such as neurotoxins, to which said animals, such as humans, have been, or may become, exposed.
查看更多